Itraconazole: Difference between revisions
From IDWiki
(added adverse effects) |
(→) |
||
| Line 8: | Line 8: | ||
== Adverse Effects == |
== Adverse Effects == |
||
| − | * Headaches |
+ | * [[Has adverse drug reaction::Headaches]] |
| − | * Relative adrenal insufficiency |
+ | * [[Has adverse drug reaction::Relative adrenal insufficiency]] |
| − | * Hepatotoxicity |
+ | * [[Has adverse drug reaction::Hepatotoxicity]] |
| − | * QTc prolongation |
+ | * [[Has adverse drug reaction::QTc prolongation]] |
[[Category:Antifungals]] |
[[Category:Antifungals]] |
||
Revision as of 23:05, 17 February 2020
- Azole antifungal
- Indications include Alternaria, Blastomyces dermatitidis, Chromoblastomycosis, Coccidioides immitis, Cryptococcus, Entomophthoromycotina, Exophiala, Exserohilum, Fonsecaea, Histoplasma capsulatum, Mycetoma, Paracoccidioides brasiliensis, Sappinia diploidea, Sporothrix schenckii
Therapeutic Drug Monitoring
- Should be measured 5 to 7 days after starting or changing the dose, or when interacting medications are changed
- Target in prophylaxis is a trough ot 0.5 mg/L
- Target in treatment is a trough >0.5 mg/L
